You can buy or sell PHIO and other stocks, options, ETFs, and crypto commission-free!
Phio Pharmaceuticals Corp. Common Stock, also called Phio Pharmaceutical, is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Read More Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
52 Week High
52 Week Low
— per share
Expected May 14, After Hours